Answers are grounded in this paper and cite their sources.
In a trial involving critically ill patients with severe acute kidney injury, we found no significant difference with regard to mortality between an early and a delayed strategy for the initiation of renal-replacement therapy. A delayed strategy averted the need for renal-replacement therapy in an appreciable number of patients. (Funded by the French Ministry of Health; ClinicalTrials.gov number, NCT01932190.).
No takes yet. Share an insight, caveat, or question.
Gaudry et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: